Screener
Aura Biosciences, Inc. AURA Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Aura Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The source filing: Aura Biosciences, Inc.’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-216808
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Commitments and Contingencies (Note 12) | ||
| Stockholders’ Equity: | ||
| Common stock, $0.00001 par value, 150,000,000 authorized at March 31, 2026 and December 31, 2025, and 64,150,468 and 63,587,777 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively | — | — |
| Additional paid-in capital | 621,557 | 617,433 |
| Accumulated deficit | (514,103) | (480,418) |
| Accumulated other comprehensive loss | (207) | (102) |
| Total Stockholders’ Equity | 107,247 | 136,913 |
| Total Liabilities and Stockholders’ Equity | $137,677 | $169,430 |
Item 1. Financial Statements.
FAQ
- What is Aura Biosciences, Inc.'s total equity?
- Aura Biosciences, Inc. (AURA) reported total equity of $107.25M in Q1 2026.
- How has Aura Biosciences, Inc.'s total equity changed year-over-year?
- Aura Biosciences, Inc.'s total equity decreased by 16.2% year-over-year, from $127.97M to $107.25M.
- What is the long-term trend for Aura Biosciences, Inc.'s total equity?
- Over 5 years (2020 to 2025), Aura Biosciences, Inc.'s total equity has grown at a 4.7% compound annual growth rate (CAGR), from -$108.71M to $136.91M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.
Ask your AI about Aura Biosciences, Inc.'s total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude